KLN Logistics Group’s pharmaceutical arm, KLN Pharma (Hong Kong) Limited, has been appointed as the fourth-party logistics (4PL) provider for Synmosa Biopharma (HK) Co., Ltd. The agreement positions KLN Pharma to oversee Synmosa’s entire supply chain, delivering comprehensive logistics solutions for its temperature-sensitive and time-critical products in Hong Kong.
End-to-End Solutions for a Regulated Industry
The partnership encompasses a full range of services, including inbound logistics, inventory management, order fulfillment, distribution, and regulatory support. KLN Pharma will utilize its GMP-compliant facilities, multi-temperature storage capabilities, and temperature-controlled fleet to ensure product integrity and adherence to industry regulations.
According to Samuel Lau, Managing Director for Integrated Logistics Asia at KLN, the 4PL model provides the flexibility, compliance, and scalability necessary to support Synmosa’s growth in the region.
Supporting Regional Healthcare Growth
Peihsuan Lee, Associate Vice-President of Synmosa Biopharma (HK), stated that KLN’s expertise in pharmaceutical distribution makes it an ideal partner for the company’s Hong Kong operations. The collaboration is expected to support Synmosa’s mission to deliver high-quality, science-backed therapies to patients across Asia.
With this new agreement, KLN Pharma reinforces its position as a key provider of integrated logistics solutions for the healthcare sector, leveraging its specialized infrastructure and dedicated team to manage complex supply chains in a highly regulated environment.
อัพเดตข่าวสารและบทความที่น่าสนใจในอุตสาหกรรมโลจิสติกส์ก่อนใคร ผ่าน Line Official Account @Airfreight Logistics เพียงเพิ่มเราเป็นเพื่อน @Airfreight Logistics หรือคลิกที่นี่
